RxDoctor Payments Data

David Rodriguez, MD

Family Medicine · Lake City, SCNPI 1952399222

Payments from drug & device makers

$5,050in general payments, 2019–2025

Across 317 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$697
  • Forte Bio-pharma LLC$469
  • AstraZeneca$356
  • Lilly USA, LLC$297
  • Boehringer Ingelheim$295
  • Astellas Pharma US Inc$276
  • plus $3K from 31 others

What the payments were for

  • Food & beverage$4,87597%
  • Education$1753%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,050 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$9,159
Medicare patients
48
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol74$67,870
OzempicSemaglutide42$47,466
Abilify MaintenaAripiprazole12$34,847
JardianceEmpagliflozin27$27,801
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$23,880
RexultiBrexpiprazole16$22,600
JanuviaSitagliptin Phosphate16$21,738
LinzessLinaclotide23$19,431
TrulicityDulaglutide14$18,900
EliquisApixaban14$7,943
Albuterol Sulfate HfaAlbuterol Sulfate81$2,438
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,310
Gabapentin177$2,218
Prednisone149$1,087
Celecoxib47$1,019

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$356$67,87074 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$266$57,44728 claims
Novo NordiskOzempic$189$47,46642 claims
Boehringer IngelheimJardiance$295$27,80127 claims
GSKTrelegy Ellipta$114$23,88023 claims
MerckJanuvia$116$21,73816 claims
AbbVieLinzess$697$19,43123 claims
Lilly USA, LLCTrulicity$297$18,90014 claims
PfizerEliquis$201$7,94314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Lake City

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →